Dexamethasone changes the pharmacokinetics of amitriptyline and reduces its accumulation in rat brain: The roles of P-gp and cyp3a2
The wide spread use of central nervous system (CNS) drugs has caused thousands of deaths in clinical practice while there are few antidotes or effective treatments to decrease their accumulation in CNS. In this study, we used amitriptyline (AMI) and dexamethasone (DEX) as the corresponding poisoning...
Saved in:
Main Authors: | Jing Wen (Author), Yuan Shen (Author), Min Zhang (Author), Chao Wang (Author), Yalan Xiang (Author), Hualin Cai (Author), Pingfei Fang (Author), Huande Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of asciminib in the presence of CYP3A or P‐gp inhibitors, CYP3A inducers, and acid‐reducing agents
by: Matthias Hoch, et al.
Published: (2022) -
Pharmacokinetics and Efficacy of Fluvoxamine and Amitriptyline in Depression
by: Sandra Vezmar, et al.
Published: (2009) -
Pharmacokinetic interaction between rhynchopylline and pellodendrine via CYP450 enzymes and P-gp
by: Qingzhen Meng, et al.
Published: (2021) -
Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
by: Johannes Matthaei, et al.
Published: (2021) -
Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters
by: Zhenyan Hou, et al.
Published: (2018)